Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Disposition to Issuer of 33 APTO shares, $56.76.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Aptose Biosciences Inc. (APTO) | Disposition to Issuer | 33 | $56.76 |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 3,333 | n/a |
| Jan 24, 2023 | Aptose Biosciences Inc. (APTO) | Grant/Award | 100,000 | n/a |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Jun 23, 2021 | Aptose Biosciences Inc. (APTO) | Sale | 15,400 | $51.6K |
| Jan 6, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Dec 28, 2020 | Aptose Biosciences Inc. (APTO) | Exercise/Conversion | 20,000 | $40.2K |
| Jun 25, 2020 | Aptose Biosciences Inc. (APTO) | Exercise/Conversion | 1,250 | $2.4K |
| Mar 13, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Feb 4, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 152,500 | n/a |